Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation

Brain Research

Volumn 779, Issue 1-2, 1998, Pages 177-187

  Anisman, Hymie ^a   Kokkinidis, L ^b   Borowski, Thomas ^a   Merali, Z ^c  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cytokine; Interleukin 1; Interleukin 2; Interleukin 6; Intracranial self stimulation; Psychoneuroimmunology; Reward

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; APPETITE; AROUSAL; ARTICLE; CONTROLLED STUDY; HYPOTHALAMUS; ILLNESS BEHAVIOR; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RAT; REINFORCEMENT; REWARD;

ANIMALS; ELECTRIC STIMULATION; HYPOTHALAMIC AREA, LATERAL; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; MALE; RATS; RATS, WISTAR; REWARD; SELF STIMULATION;

EID: 0031964955     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01114-1     Document Type: Article

References (73)

1. 3H]dopamine in rat cultured mesencephalic cells. J. Neurochem. 61:1993;1284-1290.
2. Anisman H., Kokkinidis L., Merali Z. Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res. 731:1996;1-11.
3. Anisman H., Zalcman S., Zacharko R.M. The impact of stressors on immune and central neurotransmitter activity: bidirectional communication. Rev. Neurosci. 4:1993;147-180.
4. Araujo B.M., Lapchak P.A., Collier B., Quirion R. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 498:1989;257-266.
5. Bauer C., Weingarten S., Senn M., Langhans W. Limited importance of a learned aversion in the hypophagic effect of interleukin-1 beta. Physiol. Behav. 57:1995;1145-1153.
6. H.O. Besedovsky, A. Del Rey, Physiological implications of the immune-neuro-endocrine network, in: R. Ader, D.L. Felten, N. Cohen (Eds.), Psychoneuroimmunology, Academic Press, San Diego, 1990, pp. 589-608.
7. Blalock J.E. The syntax of immune-endocrine communication. Immunol. Today. 15:1994;504-544.
8. Bluthe R.M., Dantzer R., Kelley K.W. CRF is not involved in the behavioural effects of peripherally injected interleukin-1 in the rat. Neurosci. Res. Commun. 5:1989;149-154.
9. Bret-Dibat J.L., Bluthe R.M., Kent S., Kelley K.W., Dantzer R. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav. Immun. 9:1995;242-246.
10. Caraceni A., Martini C., Belli F., Mascheroni L., Rivoltini L., Arienti F., Cascinelli N. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. Eur. J. Cancer. 29A:1992;1266-1269.
11. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 542:1991;330-335.
12. Dantzer R., Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 44:1989;1995-2008.
13. Denicoff K.D., Rubinow D.R., Papa M.Z., Simpson L., Seipp L.A., Lotze M.T., Chang A.E., Rosenstein D., Rosenberg S.A. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Int. Med. 107:1987;293-300.
14. Deutch A.Y., Tam S.-Y., Roth R.H. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res. 333:1985;143-146.
15. A.J. Dunn, Interaction between the nervous system and the immune system: implications for psychopharmacology, in: F.E. Bloom, D.J. Kupfer (Eds.), Psychopharamacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 719-731.
16. Dunn A.J. Interleukin-1 as a stimulator of hormone secretion. Prog. Neurol. Endocrinol. Immunol. 3:1990;26-34.
17. Dunn A.J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci. 43:1988;429-435.
18. H.C. Fibiger, A.G. Phillips, Mesocorticolimbic dopamine systems and reward, in: P. Kalivas, C.B. Nemeroff (Eds.), The Mesocorticolimbic Dopamine System, New York Academy of Sciences, New York, 1988, pp. 206-215.
19. Harbuz M.S., Stephanou A., Knight R.A., Chover-Gonzalez A.J., Lightman S.L. Action of interleukin-2 and interleukin-4 on CRF mRNA in the hypothalamus and POMC mRNA in the anterior pituitary. Brain Behav. Immun. 6:1992;214-222.
20. Hart B. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12:1988;123-137.
21. Hellerstein M.K., Meydani S.N., Meydani M., Wu K., Dinarello C.A. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J. Clin. Invest. 84:1989;228-235.
22. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system. I: expression and recognition Trends Neurosci. 18:1995;83-88.
23. Imura H., Fukata J.-I., Mori T. Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin. Endocrinol. 35:1991;107-115.
24. Kabiersch A., Del Rey A., Honegger C.G., Besedovsky H.O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2:1988;267-274.
25. Kakuscka I., Qi Y., Clark B.D., Lechan R.M. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology. 133:1993;815-821.
26. Karanth S., McCann S.M. Anterior pituitary hormone control by interleukin-2. Proc. Natl. Acad. Sci. USA. 88:1991;2961-2965.
27. Karanth S., McCann S.M. Influence of dopamine on the altered release of prolactin, leutenizing hormone, and follicle stimulating hormone induced by interleukin-2 in vitro. Neuroendocrinology. 56:1992;871-880.
28. Kent S., Bret-Dibat J.L., Kelley K.W., Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 20:1995;171-175.
29. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharamacol. Sci. 12:1992;24-28.
30. Kokkinidis L., McCarter L. Postcocaine depression and sensitization of brain stimulation reward: analysis of reinforcement and performance effects. Pharmacol. Biochem. Behav. 36:1990;463-471.
31. Krueger J.M., Takahashi S., Kapas L., Bredow S., Roky R., Fang J., Floyd R., Renegar K.B., Guha-Thakurta N., Novitsky S., Obal F. Cytokines in sleep regulation. Adv. Neuroimmunol. 5:1995;171-188.
32. Lacosta S., Merali Z., Anisman H. Cytokine-induced endocrine, neurochemical and behavioral alterations. Soc. Neurosci. Abstr. 21:1995;1397.
33. Lacosta S., Merali Z., Anisman H., Bielajew C. Systemic interleukin-1β and mild stress rapidly and additively increase interstitial levels of 5-HIAA and HVA at the nucleus accumbens. Soc. Neurosci. Abstr. 20:1994;955.
34. Lapchak P.A. A role for interleukin-2 in the regulation of striatal dopaminergic function. NeuroReport. 3:1992;165-168.
35. Lapchak P.A., Araujo D.M., Quirion R., Beaudet A. Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience. 44:1991;173-184.
36. Linthorst A.C.E., Flachskamm C., Muller-Preuss P., Holsboer F., Ruel J.M.H.M. Effect of bacterial endotoxin and interleukin-1β on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J. Neurosci. 15:1995;2920-2934.
37. Lyson K., McCann S.M. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology. 54:1991;262-266.
38. Maier S.F., Watkins L.R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695:1995;279-282.
39. Masana M.I., Heyes M.P., Mefford I.N. Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 14:1990;609-621.
40. McCarthy D.O., Kluger M.J., Vander A.J. Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats. Physiol. Behav. 36:1986;745-749.
41. Merali Z., Lacosta S., Anisman H. Effects of interleukin-1β and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res. 761:1997;225-235.
42. Merrill J.E. Interleukin-2 effects in the central nervous system. Ann. New York Acad. Sci. 594:1990;188-199.
43. Meyers C.A., Valentine A.D. Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs. 3:1995;56-68.
44. Mohankumar P.S., Thyagarajan S., Quadri S.K. Interleukin-1β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo. Brain Res. Bull. 31:1993;745-748.
45. Mohankumar P.S., Thyagarajan S., Quadri S.K. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from hypothalamus in vivo. Life Sci. 48:1991;925-930.
46. Moldofsky H. Central nervous system and peripheral immune functions and the sleep-wake system. J. Psychiat. Neurosci. 19:1994;368-374.
47. Nisenbaum L.K., Abercrombie E.D. Enhanced tyrosine hydroxylation in hippocampus of chronically stressed rats upon exposure to a novel stressor. J. Neurochem. 58:1992;276-281.
48. Nisenbaum L.K., Zigmond M.J., Sved A.F., Abercrombie E.D. Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J. Neurosci. 11:1991;1478-1484.
49. Nistico G. Communications among central nervous system, endocrine and immune systems: interleukin-2. Prog. Neurobiol. 40:1993;463-475.
50. Nistico G., De Sarro G. Is interleukin 2 a neuromodulator in the brain? Trends Neurosci. 14:1991;146-150.
51. Oitzl M.S., van Oers H., Schobitz B., de Kloet E.R. Interleukin-1, but not interleukin-6, impairs spatial navigation learning. Brain Res. 613:1993;160-163.
52. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
53. Payne L.C., Obal F., Krueger J.M. Hypothalamic releasing hormones mediating the effects of interleukin-1 on sleep. J. Cell. Biochem. 53:1993;309-313.
54. Perlstein R.S., Whitnall M.H., Abrams J.S., Mougey E.H. Synergistic roles of interleukin-6, interleukin-1 and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology. 132:1993;946-952.
55. Petitto J.M., McCarthy D.B., Rinker C.M., Huang Z., Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 73:1997;183-190.
56. Plata-Slaman C.R. Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15:1991;185-215.
57. Puglisi-Allegra S., Imperato A., Angelucci L., Cabib S. Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res. 554:1991;217-222.
58. Raber J., Koob G.F., Bloom F.E. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signalling; comparison with the hypothalamic response. J. Pharmacol. Exp. Ther. 272:1995;815-824.
59. Rabin B.S., Cohen S., Ganguli R., Lysle D.T., Cunnick J.E. Bidirectional interaction between the central nervous system and the immune system. Crit. Rev. Immunol. 9:1989;279-312.
60. Rivier C. Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat. Ann. New York Acad. Sci. 697:1993;97-105.
61. Ruhl A., Hurst S., Collins S.M. Synergism between interleukins 1 beta and 6 on noradrenergic nerves in rat myeneteric plexus. Gastroenterology. 107:1994;993-1001.
62. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R., Asai M. Interleukin-1β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J. Neurosci. 13:1993;3574-3581.
63. C. Song, Z. Merali, S. Lacosta, H. Anisman, Effects of cytokines and stress on neurotransmitter release in the nucleus accumbens: an in vivo microdialysis study, Psychoneuroimmunol. Res. Soc., 1996.
64. Spadaro F., Dunn A.J. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav. Immun. 4:1990;308-322.
65. Terao A., Oikawa M., Saito M. Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins. Brain Res. 622:1993;257-261.
66. Uehara A., Sekiya C., Takasugi Y., Namiki M., Arimura A. Anorexia induced by interleukin-1: involvement of corticotropin-releasing factor. Am. J. Physiol. 257:1989;R613-R617.
67. Wise R.A. The anhedonia hypothesis: mark III. Behav. Brain Sci. 8:1985;178-186.
68. Yang Z.J., Koseki M., Meguid M.M., Gleason J.R., Debonis D. Synergistic effects of rhTNF-alpha and rhIL-1 alpha in inducing anorexia in rats. Am. J. Physiol. 36:1994;R1056-R1064.
69. Yirmiya R., Avitsur R., Donchin O., Cohen E. Interleukin-1 inhibits sexual behavior in female but not in male rats. Brain Behav. Immun. 9:1995;220-233.
70. Zacharko R.M., Anisman H. Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci. Biobehav. Rev. 15:1991;391-405.
71. Zacharko R.M., Bowers W.J., Kokkinidis L., Anisman H. Region specific reductions of intracranial self-stimulation after uncontrollable stress: possible effects on reward processes. Behav. Brain Res. 9:1983;129-141.
72. Zalcman S., Green-Johnson J., Murray L., Nance D.M., Dyck D., Anisman H., Greenberg A. Cytokine-specific central monoamine alterations induced by interleukin (IL)-1, IL-2 and IL-6. Brain Res. 643:1994;40-99.
73. Zhou D.H., Shanks N., Riechman S.E., Liang R.M., Kusnecov A.W., Rabin B.S. Interleukin-6 modulates interleukin-1 and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology. 63:1996;227-236.